ISO 9001:2015 WHO-GMP Certified Manufacturing · 273+ Hospital Injectable Formulations · Pan-India Delivery — 25+ States · PCD franchise now open → Apply
Anti-Infectives
Critical Care
Support Therapy
Biofril Healthcare critical care injectables
273+ formulations
Critical care.
Hospital trusted.
WHO-GMP certified. Available for PCD franchise with monopoly rights across India.
Download Catalogue

When you start exploring nutraceutical manufacturing options in India, you’ll hear four terms used interchangeably: private label, white label, third party, and contract manufacturing. They overlap but they’re not identical, and choosing the wrong model costs you margin, IP, or both. This post breaks each model down with real numbers and tells you which fits your stage.

White Label Manufacturing

Manufacturer sells the same generic formulation to multiple brands. You add your label, that’s it. Identical product, different stickers. MOQ: lowest (1,000–3,000 units). Lead time: 15–30 days. Customization: label only. IP: none. Best for: very small brands, dropshippers, gift sets, hospital/clinic in-house labels.

Private Label Manufacturing

Manufacturer offers a catalog of pre-developed formulations. You select one, customize the label, and optionally tweak flavor or pack size. Composition is shared with other brands using the same formulation. MOQ: 5,000–10,000 units. Lead time: 45–75 days. Customization: label + minor (flavor, color, pack size). IP: shared. Best for: new brands wanting speed, MOQ flexibility, low risk.

Third Party Manufacturing

You provide the brand and label. The manufacturer handles formulation, production, QC, packaging, and delivery. The line between “private label” and “third party” is fuzzy in India — most use them interchangeably. MOQ: 5,000–25,000 units. Lead time: 60–90 days. Customization: moderate to high. Best for: brands ready to invest in differentiated SKUs.

Contract Manufacturing

You bring your own formulation (or commission custom R&D), the manufacturer produces it under your specifications. The recipe and IP are yours. Often involves a formal Manufacturing Services Agreement (MSA). MOQ: 25,000–100,000 units. Lead time: 90–150 days (custom development adds 12–24 weeks). Customization: complete. IP: fully yours. Best for: scaled brands, proprietary formulations, defensible IP.

Side-by-Side Comparison

Factor White Label Private Label Third Party Contract
MOQ 1k–3k 5k–10k 5k–25k 25k–100k
Custom formulation No Limited Some Full
IP ownership None Shared Mixed Yours
Lead time 15–30d 45–75d 60–90d 90–150d
Setup cost ₹10k–30k ₹40k–1L ₹75k–2L ₹3L–10L+
Per-unit cost Highest Mid-high Mid Lowest at scale
Defensibility Lowest Low Medium Highest

Which Should You Choose?

White Label if you’re testing market response with minimum capital, building a hospital/clinic in-house brand, or a corporate gifting reseller.

Private Label if you’re a new D2C brand with ₹5–15 lakhs to deploy, want to launch 1–3 SKUs quickly, will compete on brand and marketing.

Third Party if you’re past month 6 with proven sell-through, want some formulation customization, building a defensible niche.

Contract Manufacturing if your formulation is your moat, you have R&D capability or budget for custom development, hitting 50,000+ units/month per SKU, raising capital and need to demonstrate IP ownership.

Hybrid Approach (What Smart Brands Do)

Year 1: Launch 2–3 SKUs on private label. Year 2: Validate winners, expand to 5–8 SKUs still on private label. Year 3: Move winners to third party with custom flavors and proprietary blends, develop 1–2 hero SKUs as contract manufacturing. Year 4+: Bulk of revenue on contract-manufactured proprietary formulations.

IP Considerations

If commissioning custom formulations, get IP terms in writing before R&D starts: who owns the formulation specification, can the manufacturer sell it to others, exclusivity period, what happens if you change manufacturers, who owns trademarks. Standard Indian contract manufacturing agreements often default to manufacturer ownership unless you negotiate otherwise. If your formulation is strategic, pay a one-time R&D fee in exchange for IP transfer — typically ₹50,000 to ₹3 lakhs per formulation.

Cost Breakdown Example (60-cap multivitamin, 5,000 units)

White Label: ₹65/bottle, ₹15k setup, 25 days. Private Label: ₹52/bottle, ₹40k setup, 60 days. Third Party: ₹46/bottle, ₹85k setup, 75 days. Contract: ₹38/bottle (at 50k+), ₹3L one-time, 120 days.

Red Flags Across All Models

Walk away from any manufacturer that won’t share their FSSAI / WHO-GMP certificates, refuses a plant visit, quotes prices wildly below market, has no in-house QC lab, won’t provide COAs with batches, has no documented stability data, asks for 100% advance with no contractual terms.

What Biofril Offers

Biofril Healthcare’s nutraceutical manufacturing facility in Nalagarh supports all four models: private label across 95+ ready formulations from MOQ 5,000, third party manufacturing with flavor and ingredient customization, contract manufacturing with custom R&D for proprietary formulations, transparent IP terms documented in every Manufacturing Services Agreement.

Decision Framework

Ask three questions: (1) How much capital can I deploy in next 90 days? Under ₹5L → white/private label. ₹5–25L → private/third party. ₹25L+ → third party + contract. (2) What’s my moat — formulation or marketing? Marketing → private/third party. Formulation → contract. (3) How much do I care about MOQ flexibility? Critical → white/private label. Not a constraint → contract. Match the model to the answer and move.

Get a manufacturing quote across all four models →